Download PDF
CC BY-NC-ND 4.0 · J Lab Physicians 2023; 15(01): 062-068
DOI: 10.1055/s-0042-1751317
Original Article

In Vitro Efficacy of Biocompatible Zinc Ion Chelating Molecules as Metallo-β-Lactamase Inhibitor among NDM Producing Escherichia coli

Shoorashetty Manohar Rudresh
1   Department of Microbiology, ESIC Medical College, Post Graduate Institute of Medical Science and Research and Model Hospital, Bengaluru, Karnataka, India
,
Giriyapura Siddappa Ravi
1   Department of Microbiology, ESIC Medical College, Post Graduate Institute of Medical Science and Research and Model Hospital, Bengaluru, Karnataka, India
,
Yoganand Raksha
1   Department of Microbiology, ESIC Medical College, Post Graduate Institute of Medical Science and Research and Model Hospital, Bengaluru, Karnataka, India
› Author Affiliations Funding This study was funded by Rajiv Gandhi University of Health Sciences, Bengaluru (Code: M107/2016-17).
› Further Information
   Permissions and Reprints

Abstract

Objective This article assesses the effectiveness of captopril, tetracycline, and ciprofloxacin as metallo-β-lactamase (MBL) inhibitors against New Delhi metallo-β-lactamase (NDM)-producing Escherichia coli.

Materials and Methods Twenty-four well-characterized carbapenem-resistant E. coli isolates which produced NDM (n = 21) and Oxa-48-like enzymes (n = 3) were used to assess the inhibitors. The positive control organism was designed by cloning the NDM gene into pET-24a plasmid and transforming it into expression vector E. coli BL21. All the proposed inhibitors were assessed for their interaction with MBLs using checkerboard minimum inhibitory concentration (MIC) assay with imipenem and meropenem. The fractional inhibitory concentration (FIC) index was calculated to assess the activity of molecules.

Results The E. coli BL21 (DE3) pET-24a-bla NDM showed carbapenem resistance upon isopropyl β-D-1-thiogalactopyranoside induction and had MIC of 32 µg/mL for both imipenem and meropenem. For the test isolates, ∑FIC values of imipenem and meropenem with ethylenediaminetetraacetic acid (EDTA) ranged from 0.039 to 0.266 and 0.023 to 0.156, respectively. At a 256 µg/mL concentration, captopril had ∑FIC index value for imipenem and meropenem as 0.133 to 0.375 and 0.133 to 0.188, respectively. The tetracycline and ciprofloxacin in combination with meropenem/imipenem showed indifferent results.

Conclusion Among the three molecules tested, captopril had MBL inhibitory activity, but the concentration required for inhibition was beyond the therapeutic safety levels. Ciprofloxacin and tetracycline had weak or no MBL inhibitory activity. Checkerboard MIC of EDTA with carbapenem antibiotic and control organism with NDM enzyme production helped us create a reference system for comparing and assessing the results of potential MBL inhibitors in future.

Keywords

MBL inhibitors - New Delhi Metallo-β-lactamases - tetracycline - captopril - ciprofloxacin

Ethical Approval

No. 532/L/11/12/Ethics/ESICMC&PGIMSR/Estt.Vol.III Dated: 16/11/2016.




Publication History

Article published online:
17 August 2022

© 2022. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Tan X, Kim HS, Baugh K. et al. Therapeutic options for metallo-β-lactamase-producing enterobacterales. Infect Drug Resist 2021; 14: 125-142
    CrossrefPubMedGoogle Scholar
  • 2 Wade N, Tehrani KHME, Brüchle NC, van Haren MJ, Mashayekhi V, Martin NI. Mechanistic investigations of metallo-β-lactamase inhibitors: strong zinc binding is not required for potent enzyme inhibition. ChemMedChem 2021; 16 (10) 1651-1659
    CrossrefPubMedGoogle Scholar
  • 3 Boyd SE, Livermore DM, Hooper DC, Hope WW. Metallo-β-lactamases: structure, function, epidemiology, treatment options, and the development pipeline. Antimicrob Agents Chemother 2020; 64 (10) e00397-e20
    PubMedGoogle Scholar
  • 4 Bush K. Past and present perspectives on β-lactamases. Antimicrob Agents Chemother 2018; 62 (10) e01076-e18
    CrossrefPubMedGoogle Scholar
  • 5 Sharma S, Sharma S, Singh PP, Khan IA. Potential inhibitors against NDM-1 type metallo-β-lactamases: an overview. Microb Drug Resist 2020; 26 (12) 1568-1588
    CrossrefPubMedGoogle Scholar
  • 6 Palacios AR, Rossi MA, Mahler GS, Vila AJ. Metallo-β-lactamase inhibitors inspired on snapshots from the catalytic mechanism. Biomolecules 2020; 10 (06) 854
    CrossrefPubMedGoogle Scholar
  • 7 Seedher N, Agarwal P. Effect of metal ions on some pharmacologically relevant interactions involving fluoroquinolone antibiotics. Drug Metabol Drug Interact 2010; 25 (1-4): 17-24
    CrossrefPubMedGoogle Scholar
  • 8 Guerra W, Silva-Caldeira PP, Terenzi H. et al. Impact of metal coordination on the antibiotic and non-antibiotic activities of tetracycline-based drugs. Coord Chem Rev 2016; 327–328: 188-199
    CrossrefGoogle Scholar
  • 9 Brem J, van Berkel SS, Zollman D. et al. Structural basis of metallo-β-lactamase inhibition by captopril stereoisomers. Antimicrob Agents Chemother 2015; 60 (01) 142-150
    CrossrefPubMedGoogle Scholar
  • 10 Rudresh SM, Ravi GS, Sunitha L, Hajira SN, Kalaiarasan E, Harish BN. Simple, rapid, and cost-effective modified Carba NP test for carbapenemase detection among Gram-negative bacteria. J Lab Physicians 2017; 9 (04) 303-307
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40 (06) 2153-2162
    CrossrefPubMedGoogle Scholar
  • 12 Jara D, Bello-Toledo H, Domínguez M. et al. Antibiotic resistance in bacterial isolates from freshwater samples in Fildes Peninsula, King George Island, Antarctica. Sci Rep 2020; 10 (01) 3145
    CrossrefPubMedGoogle Scholar
  • 13 Sambrook J, Russell D. Molecular Cloning: A Laboratory Manual. 3rd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 2001
    Google Scholar
  • 14 Grigorenko VG, Rubtsova MY, Filatova EV. et al. Cloning and expression of NDM-1 metallo-β-lactamase gene and study of the catalytic properties of the recombinant enzyme. Mosc Univ Chem Bull 2016; 71: 104-109
    CrossrefGoogle Scholar
  • 15 Clinical and Laboratory Standards Institute (CLSI). M100–S30. Performance Standards for Antimicrobial Susceptibility Testing; 30th Informational Supplement. Wayne, PA: CLSI; 2020
    Google Scholar
  • 16 Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52 (01) 1
    CrossrefPubMedGoogle Scholar
  • 17 Azumah R, Dutta J, Somboro AM. et al. In vitro evaluation of metal chelators as potential metallo- β -lactamase inhibitors. J Appl Microbiol 2016; 120 (04) 860-867
    CrossrefPubMedGoogle Scholar
  • 18 McGeary RP, Tan DT, Schenk G. Progress toward inhibitors of metallo-β-lactamases. Future Med Chem 2017; 9 (07) 673-691
    CrossrefPubMedGoogle Scholar